earnings call
Lician Pro · $19.99/mo or $149/yr · AAPL vs MSFT
Arrowhead Pharmaceuticals Inc (ARWR) SEC filings
Arrowhead Pharmaceuticals Inc (ARWR) SEC filings — 10-K, 10-Q, 8-K, and Form 4 as cached from EDGAR. When an exhibit lands, this page shows the headline, the numbers, and why it matters.
Those exhibit numbers sit next to the income-statement cache: Latest reported ARWR revenue for 2025-09-30 was $829.4M. Net income was -$1.6M. Revenue was up 23258.2% from 2024-09-30 to 2025-09-30. ARWR currently screens at market cap $10.59B. The ARWR filings page is the source view; the stock page is the research view.
EDGAR remains the official archive. Lician caches 8-K exhibits so you can read what Arrowhead Pharmaceuticals Inc said without waiting on a live EDGAR scrape. Item 2.02 is the earnings exhibit — this page prefers EX-99.1 revenue, growth, EPS, and guidance over a form-type label. Form 4 insider prints stay on the same ticker timeline.
Earnings & events
All eventsearnings call
Event insights for ARWR — what management said, what changed, and why it matters.
Recent filings
ARWR SEC filings FAQ
What is the latest ARWR SEC filing?
The latest cached Arrowhead Pharmaceuticals Inc (ARWR) filing on this page is 8-K · Jan 12, 2026. Filings: https://lician.com/sec/arwr
What is the latest ARWR filing accession number?
The latest cached Arrowhead Pharmaceuticals Inc (ARWR) accession number on this page is 0001193125-26-010582. Filing: https://lician.com/sec/arwr/0001193125-26-010582
Which item codes are on the latest ARWR filing?
Cached item codes on the latest Arrowhead Pharmaceuticals Inc (ARWR) 8-K are 1.01, 2.03, 9.01.
How many ARWR SEC filings are listed on this page?
This page lists 2 cached Arrowhead Pharmaceuticals Inc (ARWR) SEC filings. Filings: https://lician.com/sec/arwr
What events are listed on the ARWR SEC page?
Cached event headlines on this Arrowhead Pharmaceuticals Inc (ARWR) SEC page: "ARWR earnings". Events: https://lician.com/sec/arwr
What are ARWR's latest revenue and net income?
Latest cached Arrowhead Pharmaceuticals Inc (ARWR) revenue for Sep 30, 2025 was $829.4M. Net income was -$1.6M. Statements: https://lician.com/financials/arwr